drug
ATG-031
Phase 1updated 5mo agoby Antengene Corp Ltd
Phase 1community read0 votes
indications
indications
NSCLCBreast Cancer
all catalysts(0)
nothing on the calendar yet
Trials studying ATG-031
News(1)
- Why Pheast’s CEO has no regrets about transparent approach to R&D despite competitors circlingPheast Therapeutics may have learned the hard way about the risks of competitors getting a glimpse of your heard-earned discoveries, but the immuno-oncology startup is so far sticking to its transp…fiercebiotech · 1mo ago
Data sources
last refreshed 2h ago
Found something off?
comments(0)
5-min edit window · permanent after that